No products in the cart.
Risk of myopathy and myalgia among statin users may be small and clinically insignificant
1. 27.1% of patient in the statin group reported muscle pain and weakness compared to 26.6% in the control groups. ...
Tag: cardiovascular disease
Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases
1. An increased incidence of new cardiovascular disease was seen in individuals with autoimmune disease compared to those without. 2. ...
Tea consumption is associated with decreased risk of mortality
1. This prospective cohort study found that consuming two or more cups of tea daily was associated with moderately reduced ...
Military veterans with a history of traumatic brain injury may be at increased risk of cardiovascular disease
1. In this retrospective study, traumatic brain injury in any capacity amongst United States army veterans was associated with an ...
Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
1. 3-year composite outcome of stroke and cardiovascular disease was comparable between both groups (9.1% combination vs. 9.9% monotherapy). 2. ...
Dapagliflozin associated with reduced risk of cardiovascular and kidney outcomes irrespective of background use of cardiovascular medications
1. In this secondary analysis of the DECLARE-TIMI 58 trial, among 17,160 patients, dapagliflozin consistently reduced the risk of cardiovascular ...
Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
1. Vitamin and mineral supplementation was associated with minimal to no benefit in preventing cancer, cardiovascular disease, and death. 2. ...
Unsweetened coffee consumption is associated with reduced risk of mortality
1. Moderate consumption of unsweetened and sugar-sweetened coffee was associated with reduced mortality from cancer and cardiovascular disease as compared ...
Sodium-glucose cotransporter 2 inhibitors reduce heart failure hospitalization in type 2 diabetes patients
1. In patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) use was associated with reduced risk of composite ...
Late and moderate preterm birth associated with increased cardiometabolic risk scores in young children
1. This retrospective cohort study using the TARGet Kids! Cohort demonstrated that late and moderate preterm birth was significantly associated ...
